OncoTargets and Therapy
Volume 3, 2010 - Issue
Open access
50
Views
1
CrossRef citations to date
0
Altmetric
Perspectives
Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics
Kimbach Tran Carpiuc1 Pharmerit North America LLC, Bethesda, MD, USACorrespondence[email protected]
, Gianantonio Rosti2 Department of Hematology and Oncology, S Orsola-Malpighi University Hospital, Bologna, Italy
, Fausto Castagnetti2 Department of Hematology and Oncology, S Orsola-Malpighi University Hospital, Bologna, Italy
, Maarten Treur3 Pharmerit Europe, Rotterdam, The Netherlands
& Jennifer Stephens1 Pharmerit North America LLC, Bethesda, MD, USA
Pages 205-210
|
Published online: 11 Oct 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.